World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
11158
World Ranking
17920
National Ranking
7334

Overview

Carolyn K. Goldman is affiliated with the National Institutes of Health in the United States. Their research profile shows involvement in scientific endeavors supported by this prominent federal agency known for advancing biomedical and public health knowledge.

Although detailed data on specific publications, co-authors, and specialized topics are unavailable, this affiliation positions Carolyn K. Goldman within a significant research environment that typically engages in multidisciplinary health-related studies.

The absence of recorded recent papers or publication venues precludes a detailed summary of research output, but association with NIH suggests potential engagement with a broad spectrum of biomedical fields and clinical research projects.

No awards have been noted in the available information, and there is no indication of deceased status, confirming that Carolyn K. Goldman is currently an active researcher.

Best Publications

  • Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

    Kevin C. Conlon;Enrico Lugli;Hugh C. Welles;Hugh C. Welles;Steven A. Rosenberg

  • The Sézary syndrome: a malignant proliferation of helper T cells.

    S Broder;R L Edelson;M A Lutzner;D L Nelson

  • Expression of interleukin 2 receptors on activated human B cells.

    Thomas A. Waldmann;Carolyn K. Goldman;Richard J. Robb;Joel M. Depper

  • Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex

    Mitsuru Tsudo;Robert W. Kozak;Carolyn K. Goldman;Thomas A. Waldmann

  • A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

    Jack D. Burton;Richard N. Bamford;Christian Peters;Angus J. Grant

  • The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.

    R N Bamford;A J Grant;J D Burton;C Peters

  • Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

    T A Waldmann;J D White;J A Carrasquillo;J C Reynolds

  • Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

    T A Waldmann;W C Greene;P S Sarin;C Saxinger

  • Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

    Robert B. Nussenblatt;Eric Fortin;Rhett Schiffman;Luiz Rizzo

  • The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.

    Mitsuru Tsudo;Carolyn K. Goldman;Kathleen F. Bongiovanni;Wing C. Chan

  • The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia

    TA Waldmann;JD White;CK Goldman;L Top

  • Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes.

    W Holter;C K Goldman;L Casabo;D L Nelson

  • Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2

    Thomas A. Waldmann;Carolyn K. Goldman;Kathleen F. Bongiovanni;Susan O. Sharrow

  • Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques.

    Thomas A. Waldmann;Enrico Lugli;Mario Roederer;Liyanage P. Perera

  • Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.

    Samuel Broder;David Poplack;Jacqueline Whang-Peng;Mary Durm

  • Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia.

    K. M. Debatin;Peter H. Krammer;C. K. Goldman;R. Bamford

  • Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.

    P S Brown;G L Parenteau;F M Dirbas;R J Garsia

  • APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia.

    Klaus Michael Debatin;Carolyn K. Goldman;Thomas A. Waldmann;Peter H. Krammer

  • Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates.

    Enrico Lugli;Carolyn K. Goldman;Liyanage P. Perera;Jeremy Smedley

  • Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: A fluorescence resonance energy transfer study

    Sándor Damjanovich;László Bene;János Matkó;Abdelkrim Alileche

Frequent Co-Authors

Thomas A. Waldmann
Thomas A. Waldmann National Institutes of Health
Thomas A. Fleisher
Thomas A. Fleisher National Institutes of Health
John C. Morris
John C. Morris Washington University in St. Louis
Warner C. Greene
Warner C. Greene University of California, San Francisco
Samuel Broder
Samuel Broder Precision BioSciences
Jorge A. Carrasquillo
Jorge A. Carrasquillo Memorial Sloan Kettering Cancer Center
Sándor Damjanovich
Sándor Damjanovich University of Debrecen
Susan O. Sharrow
Susan O. Sharrow National Institutes of Health
Martin W. Brechbiel
Martin W. Brechbiel National Institutes of Health
David L. Nelson
David L. Nelson Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your expertise in Biology and Biochemistry opens doors to various interdisciplinary career paths and advanced online degree options. Today, online education offers flexible learning environments, making it easier to pursue related specializations while balancing other commitments.

For those interested in pharmaceuticals, an online pharmd program can be a strategic choice, preparing graduates for pharmacy practice and research roles. If you are drawn to health, fitness, or rehabilitation sciences, consider exploring the best online exercise science degree or a kinesiology online degree. Both pathways offer opportunities in sports medicine, wellness coaching, and more.

Alternatively, those aiming for mental health nursing may be interested in the shortest pmhnp program to become a Psychiatric Mental Health Nurse Practitioner. Whichever path you choose, these online programs enhance career versatility and bring critical skills required in evolving health and science fields.

Best Scientists Citing Carolyn K. Goldman

Recently Published Articles